Alti Global, Inc. current report, 11 July 2023

AlTi Global, Inc. Form 8-K Summary

Business context and reporting period

AlTi Global, Inc. filed a Current Report on Form 8-K dated July 14, 2023, reporting an event occurring July 11, 2023. The filing concerns the separation of Christine Zhao, the Company’s previously announced departing Chief Financial Officer. AlTi Global’s Class A common stock trades on the Nasdaq Capital Market under the symbol ALTI.

Financial and liquidity information

  • Severance: Tiedemann Advisors, LLC, a subsidiary of AlTi Global, agreed to pay Ms. Zhao aggregate severance of $805,000.
  • Payment timing: The severance will be paid in scheduled lump sums, beginning within 30 days after the agreement becomes effective and ending no later than February 15, 2026.
  • Benefits: The Company will pay COBRA health insurance premiums from July 1, 2023 through the earlier of June 30, 2024 or the date Ms. Zhao becomes eligible for another employer’s group health coverage.
  • The filing does not provide revenue, profit, cash flow, margin, debt, cash balance, liquidity, or broader operating performance metrics.

Material changes versus the prior comparable period

The filing reports a separation agreement associated with the CFO’s previously announced resignation. It does not provide comparative-period financial results or quantify the accounting impact, if any, of the severance and benefits obligations.

Outlook, risks, contingencies, and unusual items

  • Ms. Zhao may revoke the agreement during a seven-day period ending July 18, 2023.
  • The agreement includes confidentiality, non-disparagement, and general release provisions, subject to customary exceptions.
  • The Company is required to instruct certain directors, officers, and others not to disparage Ms. Zhao.
  • The scheduled payments and COBRA obligation represent future cash commitments; the filing does not state the expected expense-recognition timing or funding source.
  • The exhibit description identifies the counterparty as Christine Zhou, while the body of the filing refers to Christine Zhao. This name discrepancy should be verified against the executed agreement.

Key facts for investors to verify

  • Whether the Separation Agreement became effective after the July 18, 2023 revocation period.
  • The timing and accounting treatment of the $805,000 severance obligation and related COBRA payments.
  • The identity of the departing executive, given the Zhao-versus-Zhou discrepancy in the filing.
  • The Company’s subsequent CFO appointment and any related changes to executive compensation or governance.